KRYS icon

Krystal Biotech

137 hedge funds and large institutions have $1.36B invested in Krystal Biotech in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 52 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0% less capital invested

Capital invested by funds: $1.37B → $1.36B (-$961K)

0.63% less ownership

Funds ownership: 81.7%81.07% (-0.63%)

12% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 52

Holders
137
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.2M
Puts
$3.87M
Net Calls
Net Calls Change

Top Sellers

1 -$9.59M
2 -$8.03M
3 -$4.92M
4
Jennison Associates
Jennison Associates
New York
-$4.54M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$4.02M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$7.41M
27
$7.11M
28
$6.91M
29
$6.08M
30
$5.6M
31
$5.27M
32
$5.21M
33
$3.87M
34
$3.79M
35
$3.59M
36
$3.43M
37
$2.96M
38
$2.71M
39
$2.54M
40
$2.53M
41
$2.43M
42
$2.18M
43
$2.17M
44
$2.01M
45
$1.97M
46
$1.92M
47
$1.89M
48
$1.87M
49
$1.8M
50
$1.79M